Gastro-oesophageal Reflux Disease Trial, Recruiting NCT05066594 Sponsor: IRCCS San Raffaele Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT05066594
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been assessed by a doctor as needing a specific non-surgical procedure (called TIF, using a device called EsophyX) to treat long-term acid reflux disease.
  • People who are able to attend follow-up appointments at San Raffaele Hospital over a 5-year period after the procedure.
  • People who have signed a consent form agreeing to take part in the observational registry.

Who may not be able to join:

  • People who have not been assessed by a doctor as needing the TIF procedure with the EsophyX device for long-term acid reflux disease.
  • People who are not able to commit to follow-up appointments at San Raffaele Hospital over a 5-year period after the procedure.
  • People who have not signed the consent form to participate in the observational registry.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pier Alberto Testoni, Prof., IRCCS San Raffaele

Phone: +39 02/26432756

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele
Registry
ClinicalTrials.gov
Start date
1 May 2021
Est. completion
1 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Medical use and dosage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov